Biosecurity Threat Posed by Botulinum Toxin.
biocrimes
biosecurity
bioterrorism
botulinum
botulism
poisoning
Journal
Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765
Informations de publication
Date de publication:
20 11 2019
20 11 2019
Historique:
received:
26
09
2019
revised:
03
11
2019
accepted:
13
11
2019
entrez:
24
11
2019
pubmed:
24
11
2019
medline:
18
11
2020
Statut:
epublish
Résumé
The deliberate release of biological agents with terrorist or criminal intent continues to pose concerns in the current geopolitical situation. Therefore, attention is still needed to ensure preparedness against the potential use of pathogens as unconventional weapons. Botulinum neurotoxin (BoNT) is one such biological threat, characterized by an extremely low lethal dose, high morbidity and mortality when appropriately disseminated, and the capacity to cause panic and social disruption. This paper addresses the risks of a potential release of the botulinum neurotoxin and summarizes the relevant aspects of the threat.
Identifiants
pubmed: 31757074
pii: toxins11120681
doi: 10.3390/toxins11120681
pmc: PMC6950065
pii:
doi:
Substances chimiques
Chemical Warfare Agents
0
Botulinum Toxins
EC 3.4.24.69
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Am Acad Dermatol. 2009 Jul;61(1):149-50
pubmed: 19539854
Pharmacol Rev. 2017 Apr;69(2):200-235
pubmed: 28356439
Expert Opin Drug Discov. 2017 May;12(5):497-510
pubmed: 28271909
Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S119-24
pubmed: 12569958
Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9984-9
pubmed: 15985558
Eur J Clin Microbiol Infect Dis. 2007 Jun;26(6):385-94
pubmed: 17516104
Eurasian J Med. 2010 Aug;42(2):92-4
pubmed: 25610131
Drugs R D. 2010;10(2):67-73
pubmed: 20698714
Crit Rev Microbiol. 2007 Apr-Jun;33(2):109-25
pubmed: 17558660
Mayo Clin Proc Innov Qual Outcomes. 2018 Aug 03;2(3):291-296
pubmed: 30225463
Euro Surveill. 2004 Dec;9(12):31-32
pubmed: 29183487
Toxins (Basel). 2019 Jul 17;11(7):null
pubmed: 31319550
JAMA. 1998 Mar 18;279(11):859-63
pubmed: 9516001
Mov Disord. 1988;3(4):333-5
pubmed: 3211180
Vaccine. 2009 Nov 5;27 Suppl 4:D33-9
pubmed: 19837283
Clin Microbiol Rev. 2006 Apr;19(2):298-314
pubmed: 16614251
Toxins (Basel). 2018 Sep 13;10(9):
pubmed: 30217070
Clin Infect Dis. 2005 Oct 15;41(8):1167-73
pubmed: 16163636
Crit Rev Microbiol. 2005;31(1):11-8
pubmed: 15839401
Ann Ist Super Sanita. 2009;45(2):134-46
pubmed: 19636165
JAMA. 2001 Feb 28;285(8):1059-70
pubmed: 11209178
Clin Neuropharmacol. 2010 May;33(3):158-60
pubmed: 20150804
Cell Mol Life Sci. 2006 Oct;63(19-20):2223-8
pubmed: 16964580
MMWR Morb Mortal Wkly Rep. 2011 Oct 28;60(42):1454-5
pubmed: 22031218
Toxins (Basel). 2018 May 10;10(5):
pubmed: 29748471
Infect Dis Clin North Am. 2006 Jun;20(2):313-27, ix
pubmed: 16762741
Int J Mol Sci. 2019 Mar 08;20(5):null
pubmed: 30857127
Sci Rep. 2015 Dec 16;5:17513
pubmed: 26670952
Crit Care Clin. 2005 Oct;21(4):825-39, viii
pubmed: 16168317
Handb Clin Neurol. 2008;91:333-68
pubmed: 18631849
Pediatr Rev. 2016 May;37(5):183-92
pubmed: 27139326
Toxicon. 2018 Jun 1;147:32-37
pubmed: 29111118
Gig Sanit. 1995 Jan-Feb;(1):9-12
pubmed: 7744287
Toxins (Basel). 2017 Sep 02;9(9):
pubmed: 28869493
Front Bioeng Biotechnol. 2018 Jun 22;6:80
pubmed: 29988463